Form 4: OptimizeRx Corp Executive Stephen L. Silvestro Reports Stock Disposition for Tax Obligations

Stephen L. Silvestro, Chief Commercial Officer of OptimizeRx Corp, reports the disposition of 2,298 shares of common stock to cover tax withholding obligations.

Summary

• On February 15, 2025, Stephen L. Silvestro, the Chief Commercial Officer of OptimizeRx Corp, disposed of 2,298 shares of common stock.
• The disposition was executed to satisfy the reporting person's tax withholding obligations.
• The price per share was $6.64.
• Following the transaction, Silvestro beneficially owns 119,958 shares of OptimizeRx Corp.
• The reporting person has a power of attorney.
• The filing of this statement shall not be construed as an admission that the person filing this Statement is, for the purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the beneficial owner of any equity securities covered by this Statement, or that this Statement is legally required to be filed by such person.

Sentiment

Score: 5

Explanation: This is a neutral event related to tax obligations and doesn't indicate positive or negative sentiment.

Industry Context

This is a routine filing related to executive stock transactions and is common in publicly traded companies.

Stakeholder Impact

• The transaction has a minimal impact on stakeholders as it is a routine stock disposition for tax purposes.

Key Dates

Keywords

OptimizeRx Corp, OPRX, Stephen L. Silvestro, Form 4, Beneficial Ownership, Stock Disposition, Tax Withholding, Chief Commercial Officer